{"id":"W4231972505","doi":"10.1136/annrheumdis-2019-216655","title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2766,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"European League Against Rheumatism","keywords":"Medicine; Antirheumatic drugs; Rheumatoid arthritis; Antirheumatic Agents; Disease management; Intensive care medicine; Arthritis; Disease; Biological drugs; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}